Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT06007547
PHASE4
Prophylactic Minimally Invasive Surfactant Evaluation
Sponsor: Endeavor Health
View on ClinicalTrials.gov
Summary
The purpose of this study is to explore the question: Does prophylactic administration of exogenous surfactant in the delivery room, using a minimally-invasive technique, improve outcome in preterm infants 22-29 weeks' gestation compared to rescue treatment using the same technique?
Key Details
Gender
All
Age Range
Any - 15 Minutes
Study Type
INTERVENTIONAL
Enrollment
200
Start Date
2024-01-01
Completion Date
2027-07-31
Last Updated
2025-08-07
Healthy Volunteers
Yes
Interventions
DRUG
Poractant Alfa
Poractant alfa (Curosurf) 200mg/kg administered under direct laryngoscopy using a surfactant instillation catheter
Locations (1)
Northshore University Healthsystem
Evanston, Illinois, United States